We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal appeals court has ruled that Banner Life Sciences may make and market its version of Biogen’s blockbuster multiple sclerosis drug, Tecfidera (dimethyl fumarate). Read More
The director of HHS’ Biomedical Advanced Research and Development Authority (BARDA), Rick Bright, has departed from the federal vaccine development agency to helm a new initiative on COVID-19 diagnostics at the National Institutes of Health (NIH). Read More
The United Nations adopted a resolution calling for pharma companies to waive exclusive rights for their vaccines and treatments during the COVID-19 crisis. Read More
The European Medicines Agency (EMA) recommended that good manufacturing practice (GMP) certificates for drugmakers be extended until the end of 2021 to avoid potential drug supply-chain disruptions during the pandemic. Read More
FDA Commissioner Stephen Hahn said the agency is meeting its user fee-related review goals for now as the COVID-19 outbreak rages, but the agency may not be able to sustain its current workload. Read More
The European Union has drafted a resolution calling on the World Health Organization to create a shared pool of intellectual property rights for vaccines and treatments during the coronavirus pandemic. Read More
Novo Nordisk yesterday offered free insulin for 90 days to patients who have lost their healthcare benefits because of the COVID-19 pandemic. If a patient’s Medicaid benefits are denied, assistance can be extended until the end of the year, the company said. Read More
The EMA said it will allow firms struggling to meet quality requirements when they increase manufacturing capacity to meet demand during the COVID-19 pandemic to use a risk-based approach. Read More